Senior Analyst, Corporate Development & Investor Relations
Core
Support Corporate Development, Investor Relations, and Clinical Operations initiatives to drive M&A, strategic partnerships, and business growth in the diabetes technology sector.
Role type
Senior Analyst, Corporate Development & Investor Relations
Builds
Strategic business cases, valuation analyses, investor presentations, and clinical trial execution plans
Domain
Life Sciences / Biotechnology / Diabetes Technology
Required skills
Financial modeling, Valuation analysis, Market research, Due diligence, Clinical trial strategy, Investor relations, Business case development, Strategic partnership identification, Financial planning, Data analysis
Preferred skills
Diabetes technology experience, M&A due diligence, Clinical trial processes, CFA progress, MBA
Technologies
Excel, PowerPoint
Responsibilities
Evaluate potential partnerships, licensing deals, and M&A opportunities; Support preparation of earnings materials and investor presentations; Partner with Clinical Operations to execute clinical trial initiatives; Monitor sell-side analyst models and consensus estimates; Build business cases and valuation analyses for strategic initiatives.
Seniority
Senior, hands-on IC
